Pages that link to "Q46665887"

The following pages link to Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia. (Q46665887):

Displaying 37 items.

• HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms (Q21245028) (← links)
• The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications (Q24598812) (← links)
• The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism (Q27021950) (← links)
• HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus (Q28582686) (← links)
• HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters (Q33729269) (← links)
• Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia (Q33987896) (← links)
• Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment. (Q34564973) (← links)
• Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV (Q34637577) (← links)
• Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus–infected lipoatrophic men treated with pioglitazone: a pilot study (Q34672147) (← links)
• Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. (Q34942750) (← links)
• Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease? (Q34979921) (← links)
• PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans (Q35000567) (← links)
• Metabolic syndrome in relation to cardiorespiratory fitness, active and sedentary behavior in HIV+ Hispanics with and without lipodystrophy (Q35084964) (← links)
• Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease (Q35104006) (← links)
• Whole-body proteolysis rate is elevated in HIV-associated insulin resistance. (Q35575238) (← links)
• Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis (Q35672526) (← links)
• Maternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study. (Q35927192) (← links)
• HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact (Q36007239) (← links)
• Nadir CD4+, religion, antiretroviral therapy, incidence of type 2 diabetes mellitus, and increasing rates of obesity among black Africans with HIV disease (Q36444419) (← links)
• Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study (Q36589398) (← links)
• Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes. (Q36725785) (← links)
• The role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: cellular mechanisms and clinical implications (Q36947456) (← links)
• HIV-associated dyslipidaemia: pathogenesis and treatment (Q37018213) (← links)
• Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function (Q37025613) (← links)
• Metabolic syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative? (Q37153502) (← links)
• Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance (Q37267062) (← links)
• Peroxisome proliferator activated receptor gamma 2 modulates late pregnancy homeostatic metabolic adaptations. (Q37468704) (← links)
• Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications (Q37602891) (← links)
• Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART (Q37604169) (← links)
• Endocrine and metabolic abnormalities among HIV-infected patients: a current review (Q38130907) (← links)
• Deciphering the molecular mechanisms involved in HIV-associated lipoatrophy by transcriptomics: a pilot study. (Q38438251) (← links)
• Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings (Q40507125) (← links)
• Seven-Up Is a Novel Regulator of Insulin Signaling. (Q52682509) (← links)
• Diabetes, insulin resistance, and HIV (Q82430871) (← links)
• Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism (Q83921118) (← links)
• Obesity and Weight Gain in Persons with HIV (Q89771713) (← links)
• Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome (Q92697752) (← links)